The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
LDN Social Media
Get connected with us on social networks
Dr Jonathan Collin – 12th September 2018 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Dr. Jonathan Collins who's an MD, prescribes Low Dose Naltrexone (LDN), and is the publisher of the Townsend letter.
Anthony - 11th April 2018 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Anthony shares his Alcohol Use Disorder (AUD) and Low Dose Naltrexone story on the LDN Radio Show with Linda Elsegood.
Dr Jill Cottel - January 2018 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Dr Jill Cottel shares her Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.
Dr Jill Cottel is a medical advisor for the LDN Research Trust and was a presenting doctor at the LDN Conference in Portland Oregon.
Naltrexone is a primary mu receptor antagonist and may also have an effect on delta and kappa receptors. The recommended dose for treatment of opiate and alcohol addiction is between 50 and 100 mg per day. It is available as naltrexone hydrochloride, a 50 mg tablet and is administered on a daily basis.
Dickson Chemist developed a new formulation of LDN which will hopefully improve the outcomes for patients. This new formulation is a more concentrated liquid in the form of drops which are administered under the tongue and absorbed directly from the mucosal lining of the mouth. This sublingual route produces a more rapid absorption bypassing the liver and digestive tract. There are several potential advantages to this, the drug may be more effective and will not be affected by the presence of food stuffs or the hostile environment of the gut.